EUVIMEDEUVIMED entdecken
Crossref

SMARCC2 silencing suppresses oncogenic activation through modulation of chromatin accessibility in breast cancer

Zhaoran Sun, Zhongkun Wang, Yirao Zhang, Xue Li, Hanchi Zhou, Simin Shao, Haowei Cao, Hao Liu, Daoyong Zhang

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.150223 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Zhaoran Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Brain Disease and Bioinformation, Xuzhou Medical University, Xuzhou, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Chromatin, Gene Silencing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SWI/SNF chromatin remodeling complexes play a key role in gene transcription as epigenetic regulators and are typically considered to act as tumor suppressors in cancers. Compared to other cancer-related components of the SWI/SNF complex, research on SMARCC2, a component of the initial BAF core, has been relatively limited. This study aimed to elucidate the role of SMARCC2 in breast cancer by employing various in vitro and in vivo methods including cell proliferation assays, mammosphere formation, and xenograft models, complemented by RNA-seq, ATAC-seq, and ChIP analyses. The results showed that SMARCC2 silencing surprisingly led to the suppression of breast tumorigenesis, indicating a pro-tumorigenic function for SMARCC2 in breast cancer, which contrasts with the roles of other SWI/SNF subunits. In addition, SMARCC2 depletion reduces cancer stem cell features of breast cancer cells. Mechanistic study showed that SMARCC2 silencing downregulated the oncogenic Ras-PI3K signaling pathway, likely by directly regulating the chromatin accessibility of the enhancers of the key genes such as PIK3CB. Together, these results expand our understanding of the SWI/SNF complex's role in cancer development and identify SMARCC2 as a promising new target for breast cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsChromatinGene SilencingHumansFemaleAnimalsCell Line, TumorGene Expression Regulation, NeoplasticMiceTranscription FactorsCell ProliferationCarcinogenesisChromosomal Proteins, Non-HistoneSignal TransductionMice, NudeChromatin Assembly and Disassembly

Stichwörter der Autor:innen

Cancer stem cellChromatin accessibilityPI3KSMARCC2SWI/SNF

Substanzen

ChromatinTranscription FactorsChromosomal Proteins, Non-Histone

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of Brain Disease and Bioinformation, Xuzhou Medical University, Xuzhou, China.
  • Jiangsu Key Laboratory of Brain Disease and Bioinformation, Xuzhou Medical University, Xuzhou, China; School of Pharmacy, Bengbu Medical University, Bengbu, Anhui, China.
  • School of Pharmacy, Bengbu Medical University, Bengbu, Anhui, China. Electronic address: liuhao6886@foxmail.com.
  • Jiangsu Key Laboratory of Brain Disease and Bioinformation, Xuzhou Medical University, Xuzhou, China. Electronic address: zhangdaoyong@tsinghua.org.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Sun, Z., Wang, Z., Zhang, Y., Li, X., Zhou, H., Shao, S., Cao, H., Liu, H., & Zhang, D. (2024). SMARCC2 silencing suppresses oncogenic activation through modulation of chromatin accessibility in breast cancer. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150223

Vancouver

Sun Z, Wang Z, Zhang Y, Li X, Zhou H, Shao S, et al. SMARCC2 silencing suppresses oncogenic activation through modulation of chromatin accessibility in breast cancer. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150223

BibTeX
@article{Sun2024,
  author = {Sun, Zhaoran and Wang, Zhongkun and Zhang, Yirao and Li, Xue and Zhou, Hanchi and Shao, Simin and Cao, Haowei and Liu, Hao and Zhang, Daoyong},
  title = {SMARCC2 silencing suppresses oncogenic activation through modulation of chromatin accessibility in breast cancer},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.150223}
}
Kostenlos starten →